+

BR9707566A - Derivados feniletanolamino tetralincarboxamida 3,4-dissubstituidos - Google Patents

Derivados feniletanolamino tetralincarboxamida 3,4-dissubstituidos

Info

Publication number
BR9707566A
BR9707566A BR9707566A BR9707566A BR9707566A BR 9707566 A BR9707566 A BR 9707566A BR 9707566 A BR9707566 A BR 9707566A BR 9707566 A BR9707566 A BR 9707566A BR 9707566 A BR9707566 A BR 9707566A
Authority
BR
Brazil
Prior art keywords
carbon atom
amino
disubstituted
configuration
tetralincarboxamide
Prior art date
Application number
BR9707566A
Other languages
English (en)
Other versions
BR9707566B1 (pt
Inventor
Makio Kitazawa
Kosuke Okazaki
Tetsuro Tamai
Masaru Saito
Nobuyuki Tanaka
Hiroaki Tobayashi
Ken Kikuchi
Hideyuki Muranaka
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13386565&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9707566(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of BR9707566A publication Critical patent/BR9707566A/pt
Publication of BR9707566B1 publication Critical patent/BR9707566B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
BRPI9707566-3A 1996-02-19 1997-02-18 derivados de feniletanolamino tetralincarboxamida 3,4-dissubstituidos. BR9707566B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6888596 1996-02-19
PCT/JP1997/000424 WO1997030023A1 (fr) 1996-02-19 1997-02-18 Derives de phenylethanolaminotetralinecarboxamide 3,4-disubstitue

Publications (2)

Publication Number Publication Date
BR9707566A true BR9707566A (pt) 1999-07-27
BR9707566B1 BR9707566B1 (pt) 2010-08-10

Family

ID=13386565

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9707566-3A BR9707566B1 (pt) 1996-02-19 1997-02-18 derivados de feniletanolamino tetralincarboxamida 3,4-dissubstituidos.

Country Status (24)

Country Link
US (1) US6133266A (pt)
EP (1) EP0882704B1 (pt)
JP (1) JP3892045B2 (pt)
KR (1) KR100491633B1 (pt)
CN (1) CN1100032C (pt)
AT (1) ATE225767T1 (pt)
AU (1) AU725042B2 (pt)
BR (1) BR9707566B1 (pt)
CA (1) CA2245490C (pt)
CZ (1) CZ293974B6 (pt)
DE (1) DE69716242T2 (pt)
DK (1) DK0882704T3 (pt)
EA (1) EA002143B1 (pt)
ES (1) ES2184989T3 (pt)
HU (1) HU229400B1 (pt)
ID (1) ID16091A (pt)
MY (1) MY123853A (pt)
NO (1) NO323095B1 (pt)
NZ (1) NZ331445A (pt)
PL (1) PL186411B1 (pt)
PT (1) PT882704E (pt)
SG (1) SG72727A1 (pt)
TW (1) TW375604B (pt)
WO (1) WO1997030023A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009001A1 (fr) * 1997-08-19 1999-02-25 Kissei Pharmaceutical Co., Ltd. Derives de phenylethanolaminotetraline et bronchodilatateurs
ZA994264B (en) 1998-07-01 2000-01-25 Warner Lambert Co Stereoisomers with high affinity for adrenergic receptors.
GB9913083D0 (en) 1999-06-04 1999-08-04 Novartis Ag Organic compounds
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors
FR2809725B1 (fr) * 2000-06-06 2004-05-07 Sanofi Synthelabo Propanolaminotetralines, leur preparation et compositions pharmaceutiques en contenant
GB0029562D0 (en) 2000-12-04 2001-01-17 Novartis Ag Organic compounds
WO2004064825A1 (ja) * 2003-01-22 2004-08-05 Kissei Pharmaceutical Co., Ltd. 子宮内胎児発育遅延又は妊娠中毒症の予防又は治療剤
JPWO2006054514A1 (ja) * 2004-11-19 2008-05-29 キッセイ薬品工業株式会社 神経因性疼痛の予防又は治療用医薬組成物
CA2589001A1 (en) * 2004-11-19 2006-05-26 Kissei Pharmaceutical Co., Ltd. Preventive or therapeutic agent for neuropathic pain
EP2098511A1 (en) 2008-03-07 2009-09-09 Solvias AG Process for preparing compounds containing a hydronaphtalene structure with an unsymmetrically substituted benzene ring
CN102365017A (zh) * 2009-11-18 2012-02-29 美迪诺亚公司 哮喘急性恶化的治疗及减少哮喘患者住院治疗的可能性
CA2791984A1 (en) * 2010-03-08 2011-09-15 Medicinova, Inc. Compositions, methods, and devices for the treatment of dysmenorrhea
US8518995B2 (en) * 2010-04-08 2013-08-27 Medicinova, Inc. Methods and compositions for the treatment of irritable bowel syndrome

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9107827D0 (en) * 1991-04-12 1991-05-29 Fujisawa Pharmaceutical Co New ethanolamine derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
IL104567A (en) * 1992-02-03 1997-03-18 Fujisawa Pharmaceutical Co Ethanolamine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
WO1993018007A1 (en) * 1992-03-13 1993-09-16 Tokyo Tanabe Company Limited Novel carbostyril derivative

Also Published As

Publication number Publication date
CN1216526A (zh) 1999-05-12
DE69716242T2 (de) 2003-07-24
KR100491633B1 (ko) 2005-09-09
PL186411B1 (pl) 2004-01-30
KR19990082638A (ko) 1999-11-25
NZ331445A (en) 2000-01-28
US6133266A (en) 2000-10-17
EP0882704B1 (en) 2002-10-09
DK0882704T3 (da) 2003-02-17
CA2245490A1 (en) 1997-08-21
CZ293974B6 (cs) 2004-09-15
CN1100032C (zh) 2003-01-29
ID16091A (id) 1997-09-04
CA2245490C (en) 2005-10-25
ATE225767T1 (de) 2002-10-15
PL328530A1 (en) 1999-02-01
AU725042B2 (en) 2000-10-05
AU2001497A (en) 1997-09-02
HU229400B1 (en) 2013-12-30
BR9707566B1 (pt) 2010-08-10
NO983777D0 (no) 1998-08-18
WO1997030023A1 (fr) 1997-08-21
JP3892045B2 (ja) 2007-03-14
NO983777L (no) 1998-10-19
EP0882704A1 (en) 1998-12-09
DE69716242D1 (de) 2002-11-14
EA199800644A1 (ru) 1999-02-25
NO323095B1 (no) 2007-01-02
MY123853A (en) 2006-06-30
EP0882704A4 (en) 2000-06-14
EA002143B1 (ru) 2001-12-24
HUP9900621A2 (hu) 1999-08-30
TW375604B (en) 1999-12-01
CZ252398A3 (cs) 1998-12-16
ES2184989T3 (es) 2003-04-16
SG72727A1 (en) 2000-05-23
PT882704E (pt) 2003-02-28
HUP9900621A3 (en) 1999-11-29

Similar Documents

Publication Publication Date Title
BR9707566A (pt) Derivados feniletanolamino tetralincarboxamida 3,4-dissubstituidos
ES2141137T3 (es) Agentes terapeuticos para la enfermedad de parkinson.
MX19368A (es) Procedimiento para la preparacion de derivados heterociclicos que contienen nitrogeno benzofusionado y compuesto obtenido.
EP0640601A4 (en) Benzamide derivative.
DK0572635T3 (da) Hidtil ukendte forbindelser med guanidinstruktur og farmaceutisk komposition indeholdende forbindelserne
NO913023D0 (no) Nye bicykliske aminosubstituerte forbindelsr.
DE69713319D1 (de) 3,4-disubstituierte phenylethanolaminotetralincarboxylat-derivate
ATE170851T1 (de) Guanidinothiazolederivate und ihre anwendung als h2-rezeptor-antagonisten
ATE344792T1 (de) Phenylethanolaminotetralincarboxamid-derivate
KR920008034A (ko) 항고혈압 작용 및 혈관 확장 활성있는 벤조피란 유도체, 그의 제법 및 그의 치료적 용도
IL83216A (en) 1((5-(10->9)abeo-6-methylergolin-8beta-yl)methyl)-imidazolidine-(and hexahydropyrimidine)-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them
AU1732697A (en) Therapeutic agent for kidney diseases
EP0420464A3 (en) 3-isoxazolone derivatives, their preparation and their therapeutic uses
ECSP972209A (es) Nuevos compuestos, procedimientos para su preparacion, composiciones, farmaceuticas y su uso en terapia

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL.8: C07C 235/06, C07C 235/86 ,C07D 295/ 185, A61K 31/165, A61K 31/402, A61K 31/445, A61K 31/5375, A61P 9/00, A61P 9/06, A61P 11/00, A61P 11/08, A61P 13/00, A61P 13/04, A61P 15/00, A61P 15/06

Ipc: C07C 235/06, C07C 235/86, C07D 295/185, A61K 31/16

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE ESTE NAO ATENDE AO REQUISITO DE ATIVIDADE INVENTIVA ( ARTIGO 8O COMBINADO COM O ARTIGO 13 DA LEI 9279 DE 1996.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/08/2010, OBSERVADAS AS CONDICOES LEGAIS.

B24B Patent annual fee: requirement for complementing annual fee

Free format text: COMPLEMENTAR A RETRIBUICAO DA 17A ANUIDADE DE ACORDO COM A TABELA VIGENTE, REFERENTE A GUIA DE RECOLHIMENTO 921301839123.

B22O Other matters related to patents and certificates of addition of invention: legal action concerning patent

Free format text: INPI-52400.061555/2013 ORIGEM: JUIZO DA 013A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO 0132366-77.2013.4.02.5101 ACAO DE NULIDADE DAS PATENTES SUBMETIDAS AO MAILBOX (ART. 229, PARAGRAFO UNICO DA LPI); ALTERNATIVAMENTE, A DECRETACAO DA NULIDADE PARCIAL PARA CORRECAO DO PRAZO DE VIGENCIA; SUBSIDIARIAMENTE, CASO SE ENTENDA NAO SER O CASO DE NULIDADE, A CORRECAO DO ATO ADMINISTRATIVO PARA ADEQUACAO DA VIGENCIA DAS PATENTES. AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU: CORIXA CORPORATION,DAIICHI PHARMACEUTICAL CO., LTD, EURO-CETIQUE S.A, IPSEN PHARMA S.AS. , KISSEI PHAMACEUTICAL CO., LTD.

B21B Extinction acc. art. 78, item ii - on waiver by the patentee, without prejudice to the rights of third parties

Free format text: SOLICITADA ATRAVES DA PETICAO 20130090955 (RJ), DE 02/12/2013

B24D Patent annual fee: restoration after fee payment
B19A Notification of judicial decision: notification of judicial decision

Free format text: INPI- 52400.061555/2013 SECAO JUDICIARIA DO ESTADO DO RIO DE JANEIRO 13A VARA FEDERAL DO RIO DE JANEIRO ACAO ORDINARIA PROCESSO NO 0132366-77.2013.4.02.5101 AUTOR: INPI REUS:CORIXA CORPORATION, DAIICHI PHARMACEUTICAL CO., LTD, EURO-CETIQUE S.A, IPSEN PHARMA S.A.S., KISSEI PHARMACEUTICAL CO. LTD. DECISAO: I DA PERDA DO OBJETO QUANTO AS PATENTES PI9612997-2, PI9608040-0, PI9506779-5, PI9508687-0 E PI9707566-3 PELA EXTINCAO DO PRESENTE FEITO EM RELACAO A ESTAS PATENTES, COM BASE NO ART. 267, INCISO VI, DO CPC, PELA PERDA DO OBJETO. II DA PATENTE PI9611455-0, DE TITULARIDADE DA EMPRESA CORIXA CORPORATION, JULGO PROCEDENTE A PRETENSAO DO INPI PARA DETERMINAR A REDUCAO DO PRAZO DE VIGEN

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载